Table 1.
Group | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|
Gender | Male | Positive | 187 | 222 | 228 | 235 | 187 | 172 | 159 | 165 |
Total | 40384 | 42,363 | 46,024 | 48,304 | 54,322 | 53,969 | 58,035 | 59,092 | ||
Prevalence | 0.46% | 0.52% | 0.50% | 0.49% | 0.34% | 0.32% | 0.27% | 0.28% | ||
Female | Positive | 149 | 165 | 166 | 157 | 141 | 105 | 133 | 89 | |
Total | 23678 | 25,967 | 26,883 | 29,297 | 28,649 | 30,824 | 34,060 | 33,980 | ||
Prevalence | 0.63% | 0.64% | 0.62% | 0.54% | 0.49% | 0.34% | 0.39% | 0.26% | ||
χ2 | 7.904 | 3.546 | 4.707 | 0.885 | 10.423 | 0.261 | 9.219 | 0.237 | ||
P value | 0.005 | 0.060 | 0.030 | 0.347 | 0.001 | 0.609 | 0.002 | 0.626 | ||
Region | Local | Positive | 45 | 50 | 45 | 66 | 55 | 43 | 36 | 37 |
Total | 17073 | 16,207 | 17,417 | 17,969 | 20,667 | 21,393 | 22,759 | 26,967 | ||
Prevalence | 0.26% | 0.31% | 0.26% | 0.37% | 0.27% | 0.20% | 0.16% | 0.14% | ||
Foreign | Positive | 291 | 337 | 349 | 326 | 273 | 234 | 256 | 217 | |
Total | 46860 | 52,034 | 55,396 | 59,488 | 62,193 | 63,377 | 69,262 | 66,110 | ||
Prevalence | 0.62% | 0.65% | 0.63% | 0.55% | 0.44% | 0.37% | 0.37% | 0.33% | ||
χ2 | 30.579 | 25.207 | 34.006 | 8.950 | 11.752 | 13.896 | 24.210 | 25.685 | ||
P value | <0.001 | <0.001 | <0.001 | 0.003 | 0.001 | <0.001 | <0.001 | <0.001 | ||
Donation history | First-time | Positive | 311 | 361 | 370 | 370 | 302 | 260 | 273 | 229 |
Total | 55358 | 59,699 | 63,858 | 66,965 | 71,651 | 72,771 | 78,802 | 43,012 | ||
Prevalence | 0.56% | 0.60% | 0.58% | 0.55% | 0.42% | 0.36% | 0.35% | 0.53% | ||
Repeat | Positive | 25 | 26 | 24 | 22 | 26 | 17 | 19 | 25 | |
Total | 8704 | 8631 | 9049 | 10,636 | 11,320 | 12,022 | 13,293 | 50,065 | ||
Prevalence | 0.29% | 0.30% | 0.27% | 0.21% | 0.23% | 0.14% | 0.14% | 0.05% | ||
χ2 | 10.868 | 12.331 | 14.556 | 21.822 | 9.134 | 14.767 | 14.904 | 197.891 | ||
P value | 0.001 | <0.001 | <0.001 | <0.001 | 0.003 | <0.001 | <0.001 | <0.001 | ||
Education level | Lower | Positive | 233 | 288 | 308 | 295 | 248 | 207 | 218 | 191 |
Total | 35061 | 38,983 | 42,131 | 43,670 | 44,792 | 45,103 | 47,924 | 43,447 | ||
Prevalence | 0.80% | 0.98% | 1.00% | 0.87% | 0.65% | 0.52% | 0.45% | 0.44% | ||
Higher | Positive | 103 | 99 | 86 | 97 | 80 | 70 | 74 | 63 | |
Total | 28972 | 29,337 | 30,772 | 33,913 | 38,164 | 39,685 | 44,160 | 49,304 | ||
Prevalence | 0.29% | 0.25% | 0.20% | 0.22% | 0.18% | 0.16% | 0.17% | 0.13% | ||
χ2 | 29.025 | 47.868 | 67.465 | 57.665 | 61.936 | 51.760 | 60.020 | 82.235 | ||
P value | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | ||
Age | 18–29 | Positive | 82 | 102 | 101 | 93 | 64 | 74 | 66 | 65 |
Total | 9124 | 14,208 | 19,309 | 22,431 | 25,174 | 30,674 | 36,741 | 36,381 | ||
Prevalence | 0.90% | 0.72% | 0.52% | 0.41% | 0.25% | 0.24% | 0.18% | 0.18% | ||
30–39 | Positive | 138 | 147 | 137 | 132 | 107 | 83 | 82 | 65 | |
Total | 27513 | 28,234 | 27,840 | 28,718 | 29,815 | 28,374 | 28,997 | 29,751 | ||
Prevalence | 0.50% | 0.52% | 0.49% | 0.46% | 0.36% | 0.29% | 0.28% | 0.22% | ||
40–49 | Positive | 100 | 118 | 128 | 139 | 122 | 89 | 95 | 90 | |
Total | 18126 | 17,193 | 17,159 | 17,842 | 18,898 | 17,652 | 18,444 | 18,914 | ||
Prevalence | 0.55% | 0.69% | 0.75% | 0.78% | 0.65% | 0.50% | 0.52% | 0.48% | ||
50–60 | Positive | 16 | 20 | 28 | 28 | 35 | 31 | 49 | 34 | |
Total | 9299 | 8695 | 8599 | 8610 | 9084 | 8093 | 7913 | 7995 | ||
Prevalence | 0.17% | 0.23% | 0.33% | 0.33% | 0.39% | 0.38% | 0.62% | 0.43% | ||
χ2 | 47.163 | 28.702 | 22.187 | 37.024 | 43.812 | 25.765 | 68.773 | 50.532 | ||
P value | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Notes: The prevalence among different groups of blood donors= Positive number of this group/Total number of this group.